SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001590750-18-000027
Filing Date
2018-11-07
Accepted
2018-11-07 17:17:17
Documents
69
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mgen-09302018x10q.htm 10-Q 1081092
2 EXHIBIT 10.2 mgen-09302018xex102.htm EX-10.2 168708
3 EXHIBIT 31.1 mgen-09302018xex311.htm EX-31.1 12682
4 EXHIBIT 31.2 mgen-09302018xex312.htm EX-31.2 12790
5 EXHIBIT 32.1 mgen-09302018xex321.htm EX-32.1 15080
  Complete submission text file 0001590750-18-000027.txt   5282409

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mgen-20180930.xml EX-101.INS 803090
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mgen-20180930_pre.xml EX-101.PRE 346327
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mgen-20180930.xsd EX-101.SCH 46323
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mgen-20180930_lab.xml EX-101.LAB 572661
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mgen-20180930_def.xml EX-101.DEF 250247
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mgen-20180930_cal.xml EX-101.CAL 64869
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 303-531-5952
MIRAGEN THERAPEUTICS, INC. (Filer) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36483 | Film No.: 181167381
SIC: 8071 Services-Medical Laboratories